Cargando…
Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe
Background and Objective: Orphan drugs have been a highlight of discussions due to their higher prices than non-orphan drugs. There is currently no European consensus on the method of value assessment for orphan drugs. This study assessed the relationship between the prevalence of rare diseases and...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Routledge
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405566/ https://www.ncbi.nlm.nih.gov/pubmed/28473888 http://dx.doi.org/10.1080/20016689.2017.1299665 |